These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34469478)

  • 1. Loss of miR-1469 expression mediates melanoma cell migration and invasion.
    DiVincenzo MJ; Barricklow Z; Schwarz E; Moufawad M; Howard JH; Yu L; Chung C; Gru AA; Carson WE
    PLoS One; 2021; 16(9):e0256629. PubMed ID: 34469478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis.
    Zhao F; Jia Z; Feng Y; Li Z; Feng J
    J Dermatol Sci; 2021 Apr; 102(1):7-15. PubMed ID: 33648800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
    Martin del Campo SE; Latchana N; Levine KM; Grignol VP; Fairchild ET; Jaime-Ramirez AC; Dao TV; Karpa VI; Carson M; Ganju A; Chan AN; Carson WE
    PLoS One; 2015; 10(1):e0115919. PubMed ID: 25587717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
    Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
    J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion.
    Margue C; Philippidou D; Reinsbach SE; Schmitt M; Behrmann I; Kreis S
    PLoS One; 2013; 8(9):e73473. PubMed ID: 24039954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.
    Cui L; Li Y; Lv X; Li J; Wang X; Lei Z; Li X
    Cell Physiol Biochem; 2016; 40(1-2):230-244. PubMed ID: 27855389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
    Chen X; Gao J; Yu Y; Zhao Z; Pan Y
    Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wan N; Yang W; Cheng H; Wang J
    Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
    Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-339-3p Is a Tumor Suppressor in Melanoma.
    Weber CE; Luo C; Hotz-Wagenblatt A; Gardyan A; Kordaß T; Holland-Letz T; Osen W; Eichmüller SB
    Cancer Res; 2016 Jun; 76(12):3562-71. PubMed ID: 27197185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
    Su BB; Zhou SW; Gan CB; Zhang XN
    J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
    Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
    J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-374 inhibits proliferation and promotes apoptosis of mouse melanoma cells by inactivating the Wnt signalling pathway through its effect on tyrosinase.
    Li XJ; Li ZF; Xu YY; Han Z; Liu ZJ
    J Cell Mol Med; 2019 Aug; 23(8):4991-5005. PubMed ID: 31207106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.